IN2013MU02227AIN2227MU2013AIN2013MU02227AIN 2013MU02227 AIN2013MU02227 AIN 2013MU02227AIN 2227MU2013 AIN2227MU2013 AIN 2227MU2013AIN 2013MU02227 AIN2013MU02227 AIN 2013MU02227A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt LtdfiledCriticalWockhardt Ltd
Priority to IN2227MU2013priorityCriticalpatent/IN2013MU02227A/en
Publication of IN2013MU02227ApublicationCriticalpatent/IN2013MU02227A/en
Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях
Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.
A composition suitable for vegetarians providing calcium supplementation as well as gout prevention and treatment and the method of preparation thereof
Preparation methods for novel creation of biologically safe klh products used in cancer therapy, development of conjugated therapeutics and as challenge agents
Preparation methods for novel creation of biologically safe klh products used in cancer therapy, development of conjugated therapeutics and as challenge agents